|
FAM116A expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.879900E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.123200E-01 |
| Normal-vs-Stage2 |
5.617400E-01 |
| Normal-vs-Stage3 |
4.502600E-03 |
| Normal-vs-Stage4 |
8.32840000000168E-05 |
| Stage1-vs-Stage2 |
5.007800E-01 |
| Stage1-vs-Stage3 |
4.041500E-04 |
| Stage1-vs-Stage4 |
1.14689999997086E-06 |
| Stage2-vs-Stage3 |
2.094200E-01 |
| Stage2-vs-Stage4 |
6.766200E-02 |
| Stage3-vs-Stage4 |
3.208400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.077180E-01 |
| Normal-vs-AfricanAmerican |
2.846100E-02 |
| Normal-vs-Asian |
2.522800E-01 |
| Caucasian-vs-AfricanAmerican |
2.810800E-01 |
| Caucasian-vs-Asian |
1.782240E-01 |
| AfricanAmerican-vs-Asian |
5.556100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.480100E-02 |
| Normal-vs-Female |
5.303800E-01 |
| Male-vs-Female |
9.374000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.336800E-01 |
| Normal-vs-Age(41-60Yrs) |
4.749400E-01 |
| Normal-vs-Age(61-80Yrs) |
5.386000E-02 |
| Normal-vs-Age(81-100Yrs) |
8.996400E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.770200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.690200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.973750E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.175760E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.665800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.049800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.963400E-03 |
| Normal-vs-Grade 2 |
3.453200E-01 |
| Normal-vs-Grade 3 |
2.823300E-04 |
| Normal-vs-Grade 4 |
3.11210000003559E-06 |
| Grade 1-vs-Grade 2 |
8.864100E-02 |
| Grade 1-vs-Grade 3 |
4.86919999986846E-07 |
| Grade 1-vs-Grade 4 |
2.45620000005609E-07 |
| Grade 2-vs-Grade 3 |
1.94780000017936E-07 |
| Grade 2-vs-Grade 4 |
6.01340000017103E-09 |
| Grade 3-vs-Grade 4 |
3.440200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.181200E-01 |
| Normal-vs-ccB subtype |
8.337800E-03 |
| ccA subtype-vs-ccB subtype |
2.31149999999625E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.111600E-01 |
| Normal-vs-N1 |
1.234130E-02 |
| N0-vs-N1 |
1.490040E-01 |
|
|
